Related references
Note: Only part of the references are listed.Is the levonorgestrel-releasing intrauterine system a risk factor for breast cancer?
Fabio R. Silva et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2021)
Levonorgestrel-releasing intrauterine system and breast cancer risk: A systematic review and meta-analysis
Livia Conz et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2020)
Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women
Britton Trabert et al.
JAMA NETWORK OPEN (2020)
Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study
Mie Jareid et al.
GYNECOLOGIC ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective
Nava Siegelmann-Danieli et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Contemporary Hormonal Contraception and the Risk of Breast Cancer
Lina S. Morch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Levonorgestrel-releasing intrauterine system and the risk of breast cancer: A nationwide cohort study
Tuuli Soini et al.
ACTA ONCOLOGICA (2016)
Progestin and breast cancer risk: a systematic review
Marsha Samson et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Use of exogenous hormones and the risk of breast cancer: results from self-reported survey data with validity assessment
Sanna Heikkinen et al.
CANCER CAUSES & CONTROL (2016)
Levonorgestrel-Releasing Intrauterine System versus Medical Therapy for Menorrhagia: A Systematic Review and Meta-Analysis
Jie Hua
MEDICAL SCIENCE MONITOR (2014)
A Re-Analysis of the Cochrane Library Data: The Dangers of Unobserved Heterogeneity in Meta-Analyses
Evangelos Kontopantelis et al.
PLOS ONE (2013)
Progesterone signalling in breast cancer: a neglected hormone coming into the limelight
Cathrin Brisken
NATURE REVIEWS CANCER (2013)
Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer
Juergen Dinger et al.
CONTRACEPTION (2011)
A case-control study on hormone therapy as a risk factor for breast cancer in Finland: intrauterine system carries a risk as well
Heli K. Lyytinen et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Hormone Action in the Mammary Gland
Cathrin Brisken et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
Chandra Kailasam
Patient Preference and Adherence (2010)
Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system Long-term follow-up of a randomised control trial
Francis J. E. Gardner et al.
GYNECOLOGIC ONCOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Use of the levonorgestrel-releasing intrauterine system and breast cancer
T Backman et al.
OBSTETRICS AND GYNECOLOGY (2005)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Share Paper
